Stock Events

Stock Events

Standard BioTools 

€0.5700
25
-€0.01-1.72% Thursday 19:56

Statistics

Day High
0.585
Day Low
0.57
52W High
1.4
52W Low
0.535
Volume
-
Avg. Volume
-
Mkt Cap
223.77M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

10NovExpected
Q1 2026
Q2 2026
Next
-0.06
-0.04
-0.03
-0.01
Expected EPS
-0.017204
Actual EPS
N/A

Financials

-86.67%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
75.65MRevenue
-65.57MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow FLB.STU. It's not an investment recommendation.
Tesla
6
TSLA
NVIDIA
5
NVDA
Coinbase Global
5
COIN
Apple
4
AAPL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap230.05B
Thermo Fisher Scientific offers a wide range of analytical instruments and laboratory equipment, directly competing with Standard BioTools' product offerings.
Danaher
DHR
Mkt Cap151.89B
Danaher Corporation operates in the life sciences sector, providing similar laboratory tools and diagnostics solutions, making it a direct competitor.
Illumina
ILMN
Mkt Cap32.55B
Illumina specializes in DNA sequencing and array-based technologies, competing in the genomics and molecular diagnostics space with Standard BioTools.
Agilent Technologies
A
Mkt Cap43.38B
Agilent Technologies provides instruments, services, and consumables in the life sciences, diagnostics, and applied chemical markets, overlapping with Standard BioTools' market.
Bio-Rad Laboratories
BIO
Mkt Cap10.37B
Bio-Rad Laboratories offers products and systems to separate complex chemical and biological materials, directly competing in the life sciences research market.
Waters
WAT
Mkt Cap40.74B
Waters Corporation specializes in analytical instruments for chromatography, mass spectrometry, and thermal analysis, competing in the analytical instruments sector.
Bruker
BRKR
Mkt Cap8.7B
Bruker Corporation designs and manufactures scientific instruments and analytical and diagnostic solutions, competing in the same space as Standard BioTools.
Qiagen NV
QGEN
Mkt Cap8.9B
QIAGEN offers sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the diagnostics and research market.
Bio-Rad Laboratories
BIO.B
Mkt Cap8.84B
Bio-Rad Laboratories, through its Class B shares, represents an alternative investment in the same company, offering similar competition in the life sciences and clinical diagnostics sectors.

About

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.
Show more...
CEO
Michael Egholm
Employees
389
Country
United States
ISIN
US34385P1084
WKN
000A0RADJ

Listings

STU
DE
FLB.STU
MU
DE
FLB.MU
F
DE
FLB.F
XNAS
US
LAB

0 Comments

Share your thoughts

FAQ

What is Standard BioTools stock price today?▼
The current price of FLB.STU is €0.57 EUR — it has decreased by -1.72% in the past 24 hours. Watch Standard BioTools stock price performance more closely on the chart.
What is Standard BioTools stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Standard BioTools stocks are traded under the ticker FLB.STU.
Is Standard BioTools stock price growing?▼
FLB.STU stock has risen by +4.59% compared to the previous week, the month change is a -19.72% fall, over the last year Standard BioTools has showed a -47.71% decrease.
What is Standard BioTools market cap?▼
Today Standard BioTools has the market capitalization of 223.77M
When is the next Standard BioTools earnings date?▼
Standard BioTools is going to release the next earnings report on November 10, 2026.
What were Standard BioTools earnings last quarter?▼
FLB.STU earnings for the last quarter are -0.06 EUR per share, whereas the estimation was -0.01 EUR resulting in a -449.02% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Standard BioTools revenue for the last year?▼
Standard BioTools revenue for the last year amounts to 75.65M EUR.
What is Standard BioTools net income for the last year?▼
FLB.STU net income for the last year is -65.57M EUR.
How many employees does Standard BioTools have?▼
As of September 04, 2026, the company has 389 employees.
In which sector is Standard BioTools located?▼
Standard BioTools operates in the Health & Wellness sector.
When did Standard BioTools complete a stock split?▼
Standard BioTools has not had any recent stock splits.
Where is Standard BioTools headquartered?▼
Standard BioTools is headquartered in BOSTON, United States.